Filing Details

Accession Number:
0001683168-20-000807
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-13 17:53:16
Reporting Period:
2020-03-13
Accepted Time:
2020-03-13 17:53:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1226616 Medicinova Inc MNOV Pharmaceutical Preparations (2834) 330927979
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1531140 Kazuko Matsuda C/O Medicinova, Inc.
4275 Executive Square, Suite 300
La Jolla CA 92037
Chief Medical Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-13 2,000 $3.62 111,476 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price ranging from $3.54 to $3.69. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Includes 289 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).